Insulin resistance is one area under investigation. If you have been diagnosed with the condition, here’s how GLP-1s may help ...
MedPage Today on MSN
Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes
No difference in insulin discontinuation rates seen among three glucose-lowering classes ...
A group of Senate Republicans wants to ensure private insurance patients with diabetes don’t have to pay more than $35 a month for insulin. The move is a major shift for a party that’s long viewed ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...
Twice daily sirolimus gel 0.2% was effective and safe for the treatment of acanthosis nigricans, a common dermatologic ...
A novel plasmid-based immunotherapy was safe and well tolerated among adults with type 1 diabetes autoantibodies, according ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
The FDA provided favorable feedback on NewcelX’s Chemistry, Manufacturing, and Controls (“CMC”) processes and preclinical program allowing the Company to proceed toward its Investigational New Drug ...
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, ...
Prostate cancer is the most common type of cancer in men, other than skin cancer. More than 1 in 10 men will get it at some point in their life. Your chances of getting prostate cancer will depend on ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results